The generation of programmable cells of monocytic origin involves partial repression of monocyte/macrophage markers and reactivation of pluripotency genes

Stem Cells and Development

Volumn 19, Issue 11, 2010, Pages 1769-1780

  Ungefroren, Hendrik ^a   Groth, Stephanie ^a   Hyder, Ayman ^a   Thomsen, Niels ^a   Hinz, Hebke ^a   Reiling, Norbert ^b   Grage Griebenow, Evelin ^b   Held Feindt, Janka ^c   Schulze, Maren ^a   Nüssler, Andreas K ^d   Fändrich, Fred ^a  

^a Department of Neurosurgery   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c Department of Neurosurgery ^*  (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE H3; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TATA BINDING PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR NANOG; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; EMBRYONIC STEM CELL; ENZYME REACTIVATION; FLOW CYTOMETRY; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT STEM CELLS; BIOLOGICAL MARKERS; CELL ADHESION; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; HEPATOCYTES; HISTONES; HUMANS; MACROPHAGES; METHYLATION; MONOCYTES; PLURIPOTENT STEM CELLS;

EID: 78049412566     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0351     Document Type: Article

References (48)

1. Schulze M, F Fändrich, H Ungefroren and B Kremer. (2005). Adult stem cells-perspectives in treatment of metabolic diseases. Acta Gastroenterol Belg 68: 461-465.
2. Gordon S and PR Taylor. (2005). Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
3. Hutchinson JA, P Riquelme, J Wundt, JG Hengstler, F Fändrich, H Ungefroren and B Clement. (2007). Could treatment with neohepatocytes benefi t patients with decompensated chronic liver disease? Am J Hematol 82: 947-948.
4. Pufe T, W Petersen, F Fändrich, D Varoga, CJ Wruck, R Mentlein, A Helfenstein, D Hoseas, S Dressel, B Tillmann and M Ruhnke. (2008). Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes. J Orthop Res 26: 304-313.
5. Ruhnke M, H Ungefroren, A Nussler, F Martin, M Brulport, W Schormann, JG Hengstler, W Klapper, K Ulrichs, JA Hutchinson, B Soria, RM Parwaresch, P Heeckt, B Kremer and F Fändrich. (2005). Differentiation of in vitro-modifi ed human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 128: 1774-1786.
6. Ruhnke M, AK Nussler, H Ungefroren, JG Hengstler, B Kremer, W Hoeckh, T Gottwald, P Heeckt and F Fandrich. (2005). Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation 79: 1097-1103.
7. Ehnert S, AK Nussler, A Lehmann and S Dooley. (2008). Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism. Drug Metab Dispos 36: 1922-1929.
8. Glanemann M, G Gaebelein, N Nussler, L Hao, Z Kronbach, B Shi, P Neuhaus and AK Nussler. (2009). Transplantation of monocyte-derived hepatocyte-like cells (NeoHeps) improves survival in a model of acute liver failure. Ann Surg 249: 149-154.
9. Yan L, Y Han, J Wang, J Liu, L Hong and D Fan. (2007). Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol 82: 949-954.
10. Wagers AJ and IL Weissman. (2004). Plasticity of adult stem cells. Cell 116: 639-648.
11. Grage-Griebenow E, D Lorenzen, R Fetting, HD Flad and M Ernst. (1993). Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol 23: 3126-3135.
12. Contreras TJ, JF Jemionek, HC Stevenson, VM Hartwig and AS Fauci. (1980). An improved technique for the negative selection of large numbers of human lymphocytes and monocytes by counterfl ow centrifugation-elutriation. Cell Immunol 54: 215-229.
13. Romagnani P, F Annunziato, F Liotta, E Lazzeri, B Mazzinghi, F Frosali, L Cosmi, L Maggi, L Lasagni, A Scheffold, M Kruger, S Dimmeler, F Marra, G Gensini, E Maggi and S Romagnani. (2005). CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97: 314-322.
14. Ungefroren H, S Groth and Fändrich F. (2006). Antioxidants and inhibitors of fl avoprotein-dependent oxidases abrogate TGF-beta induction of biglycan: evidence for a role of reactive oxygen species. Signal Transduct 6: 338-344.
15. Groth S, M Schulze, H Kalthoff, F Fändrich and H Ungefroren. (2005). Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase. J Biol Chem 280: 33190-33199.
16. Dusi S, M Donini, D Lissandrini, P Mazzi, VD Bianca and F Rossi. (2001). Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytok ines and transcriptional regulators involved. Eur J Immunol 31: 929-938.
17. Servet-Delprat C, S Arnaud, P Jurdic, S Nataf, MF Grasset, C Soulas, C Domenget, O Destaing, A Rivollier, M Perret, C Dumontel, D Hanau, GL Gilmore, MF Belin, C Rabourdin-Combe and G Mouchiroud. (2002). Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol 3: 15.
18. Feinberg MW, AK Wara, Z Cao, MA Lebedeva, F Rosenbauer, H Iwasaki, H Hirai, JP Katz, RL Haspel, S Gray, K Akashi, J Segre, KH Kaestner, DG Tenen and MK Jain. (2007). The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26: 4138-4148.
19. Tamura T, HJ Kong, C Tunyaplin, H Tsujimura, K Calame and K Ozato. (2003). ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells. Blood 102: 4547-4554.
20. Norton JD, RW Deed, G Craggs and F Sablitzky. (1998). Id helixloop-helix proteins in cell growth and differentiation. Trends Cell Biol 8: 58-65.
21. Liedtke S, M Stephan and G Kögler. (2008). Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem 389: 845-850.
22. The International Stem Cell Initiative. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25: 803-816.
23. Takeda J, S Seino and GI Bell. (1992). Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 20: 4613-4620.
24. Kotoula V, SI Papamichos and AF Lambropoulos. (2008). Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells 26: 290-291.
25. Bernstein BE, M Kamal, K Lindblad-Toh, S Bekiranov, DK Bailey, DJ Huebert, S McMahon, EK Karlsson, EJ Kulbokas III, TR Gingeras, SL Schreiber and ES Lander. (2005). Genomic maps and comparative analysis of histone modifi cations in human and mouse. Cell 120: 169-181.
26. Boyer LA, K Plath, J Zeitlinger, T Brambrink, LA Medeiros, TI Lee, SS Levine, M Wernig, A Tajonar, MK Ray, GW Bell, AP Otte, M Vidal, DK Gifford, RA Young and R Jaenisch. (2006). Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349-353. (Pubitemid 44050199)
27. Feldman N, A Gerson, J Fang, E Li, Y Zhang, Y Shinkai, H Cedar and Y Bergman. (2006). G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8: 188-194.
28. Santos-Rosa H, R Schneider, AJ Bannister, J Sherriff, BE Bernstein, NC Emre, SL Schreiber, J Mellor and T Kouzarides. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419: 407-411.
29. Cantz T, G Key, M Bleidissel, L Gentile, DW Han, A Brenne and HR Schöler. (2008). Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 26: 692-697.
30. Feinberg MW, Z Cao, AK Wara, MA Lebedeva, S Senbanerjee and MK Jain. (2005). Kruppel-like factor 4 is a mediator of proinfl ammatory signaling in macrophages. J Biol Chem 280: 38247-38258.
31. Alder JK, RW Georgantas III, RL Hildreth, IM Kaplan, S Morisot, X Yu, M McDevitt and CI Civin. (2008). Kruppel-like factor 4 is essential for infl ammatory monocyte differentiation in vivo. J Immunol 180: 5645-5652.
32. Di Stefano B, A Prigione and V Broccoli. (2009). Effi cient genetic reprogramming of unmodifi ed somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4. Stem Cells Dev 18: 707-716.
33. Shimazaki T, H Okazawa, H Fujii, M Ikeda, K Tamai, RD McKay, M Muramatsu and H Hamada. (1993). Hybrid cell extinction and re-expression of Oct-3 function correlates with differentiation potential. EMBO J 12: 4489-4498.
34. Dooner MS, JM Aliotta, J Pimentel, GJ Dooner, M Abedi, G Colvin, Q Liu, HU Weier, KW Johnson and PJ Quesenberry. (2008). Conversion potential of marrow cells into lung cells fl uctuates with cytokine-induced cell cycle. Stem Cells Dev 17: 207-219.
35. Charrière GM, B Cousin, E Arnaud, C Saillan-Barreau, M André, A Massoudi, C Dani, L Pénicaud and L Casteilla. (2006). Macrophage characteristics of stem cells revealed by transcriptome profi ling. Exp Cell Res 312: 3205-3214.
36. Mikkelsen TS, J Hanna, X Zhang, M Ku, M Wernig, P Schorderet, BE Bernstein, R Jaenisch, ES Lander and A Meissner. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49-55.
37. Zangrossi S, M Marabese, M Broggini, R Giordano, M D'Erasmo, E Montelatici, D Intini, A Neri, M Pesce, P Rebulla and L Lazzari. (2007). Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25: 1675-1680.
38. Lengner CJ, GG Welstead and Jaenisch R. (2008). The pluripotency regulator Oct4. A role in somatic stem cells? Cell Cycle 7: 725-728
39. Greco SJ, K Liu and P Rameshwar. (2007). Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 25: 3143-3154.
40. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fi broblasts by defi ned factors. Cell 131: 861-872.
41. Fukuchi Y, M Ito, F Shibata, T Kitamura and H Nakajima. (2008). Activation of CCAAT/enhancer-binding protein alpha or PU.1 in hematopoietic stem cells leads to their reduced self-renewal and proliferation. Stem Cells 26: 3172-3181.
42. Huangfu D, R Maehr, W Guo, A Eijkelenboom, M Snitow, AE Chen and DA Melton. (2008). Induction of pluripotent stem cells by defi ned factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797.
43. Seta N and M Kuwana. (2007). Human circulating monocytes as multipotential progenitors. Keio J Med 56: 41-47.
44. Zhao Y, D Glesne and E Huberman. (2003). A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 100: 2426-2431.
45. Kuwana M, Y Okazaki, H Kodama, K Izumi, H Yasuoka, Y Ogawa, Y Kawakami and Y Ikeda. (2003). Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 74: 833-845.
46. Kotake S, Y Nanke, M Mogi, M Kawamoto, T Furuya, T Yago, T Kobashigawa, A Togari and N Kamatani. (2005). IFN-gammaproducing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 35: 3353-3363.
47. Prindull GA and E Fibach. (2007). Are postnatal hemangioblasts generated by dedifferentiation from committed hematopoietic stem cells? Exp Hematol 35: 691-701.
48. Siu MK, ES Wong, HY Chan, HY Ngan, KY Chan and AN Cheung. (2008). Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol 173: 1165-1172.